ARTICLE | Clinical News

Cangene regulatory update

June 6, 1994 7:00 AM UTC

The Toronto company won a patent interference at the U.S. Patent and Trademark Office covering its Nucleic Acid Sequence-Based Amplification technology (NASBA). The interference, which began in May 1993, involved similar claims filed by Siska Diagnostics Inc. for its 3SR technology. According to CNJ, Siska has agreed not to appeal. ...